Glycogen Synthase Kinase-3: A Promising Therapeutic Target for Fragile X Syndrome

Recent advances in understanding the pathophysiological mechanisms contributing to fragile X syndrome (FXS) have increased optimism that drug interventions can provide significant therapeutic benefits. FXS results from inadequate expression of functional fragile X mental retardation protein (FMRP)....

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Mines, Marjelo A., Jope, Richard S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Research Foundation 2011
Ämnen:
Neuroscience
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3205455/
https://ncbi.nlm.nih.gov/pubmed/22053151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnmol.2011.00035
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk